Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (181-190 of 372) with videos related to

Pageof 38
Sort By:
European Journal of Heart Failure|January 6, 2022
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failureDaan Ceelen, Adriaan A Voors, Jasper Tromp, et al.
European Journal of Heart Failure|May 8, 2007
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of CardiologyMarco Metra, Piotr Ponikowski, Kenneth Dickstein, et al.
Diabetes, Obesity & Metabolism|December 22, 2022
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trialHertzel C Gerstein, Emil Wolsk, Brian Claggett, et al.
Clinical Cardiology|May 7, 2021
Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failureMasatake Kobayashi, Adriaan A Voors, Wouter Ouwerkerk, et al.
European Heart Journal|May 27, 2015
The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trialJan Steffel, Michele Robertson, Jagmeet P Singh, et al.
European Heart Journal|March 31, 2009
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failureArne Yndestad, Linn Landrø, Thor Ueland, et al.
European Heart Journal|April 21, 2017
Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trialJeroen J Bax, Victoria Delgado, Peter Sogaard, et al.
The New England Journal of Medicine|April 5, 2016
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart FailureJohn J V McMurray, Henry Krum, William T Abraham, et al.
Circulation. Cardiovascular Quality and Outcomes|August 1, 2013
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)Jonathan G Howlett, Justin A Ezekowitz, Mohua Podder, et al.
Ugeskrift for Laeger|February 16, 2006
[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication]Ida Gustafsson, Klas Malmberg, Lars Rydén, et al.
Pageof 38

Showing results (181-190 of 372) with videos related to

Sort By:
Pageof 38
European Journal of Heart Failure|January 6, 2022
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failureDaan Ceelen, Adriaan A Voors, Jasper Tromp, et al.
European Journal of Heart Failure|May 8, 2007
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of CardiologyMarco Metra, Piotr Ponikowski, Kenneth Dickstein, et al.
Diabetes, Obesity & Metabolism|December 22, 2022
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trialHertzel C Gerstein, Emil Wolsk, Brian Claggett, et al.
Clinical Cardiology|May 7, 2021
Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failureMasatake Kobayashi, Adriaan A Voors, Wouter Ouwerkerk, et al.
European Heart Journal|May 27, 2015
The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trialJan Steffel, Michele Robertson, Jagmeet P Singh, et al.
European Heart Journal|March 31, 2009
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failureArne Yndestad, Linn Landrø, Thor Ueland, et al.
European Heart Journal|April 21, 2017
Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trialJeroen J Bax, Victoria Delgado, Peter Sogaard, et al.
The New England Journal of Medicine|April 5, 2016
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart FailureJohn J V McMurray, Henry Krum, William T Abraham, et al.
Circulation. Cardiovascular Quality and Outcomes|August 1, 2013
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)Jonathan G Howlett, Justin A Ezekowitz, Mohua Podder, et al.
Ugeskrift for Laeger|February 16, 2006
[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication]Ida Gustafsson, Klas Malmberg, Lars Rydén, et al.
Pageof 38